Women's Health Trial Tracker — 2015

Name: Women's Health Trial Tracker
Creator: 1 Women’s Health
License: United States government work; public domain unless the source record says otherwise.

Record	Record Date	Vuga Group	Change Status	Recency Days
Trial of Perioperative Endocrine Therapy - Individualising Care	01/14/2015	INTERVENTIONAL	not-comparable	4,287.75
Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard Therapy	01/15/2015	INTERVENTIONAL	not-comparable	4,286.75
Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer	01/26/2015	INTERVENTIONAL	not-comparable	4,275.75
A Trial of Vigil for Participants With Ovarian Cancer	01/27/2015	INTERVENTIONAL	not-comparable	4,274.75
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ	02/02/2015	INTERVENTIONAL	not-comparable	4,268.75
GnRH for Luteal Support in IVF/ICSI/FET Cycles	02/06/2015	INTERVENTIONAL	not-comparable	4,264.75
Assessing the Impact of Contraceptives on Bone Health Using 41Ca	02/20/2015	INTERVENTIONAL	not-comparable	4,250.75
Node Negative, Invasive Breast Cancer Single Fraction IOERT	02/25/2015	INTERVENTIONAL	not-comparable	4,245.75
Sequence Variations of Genes in the Estrogen Pathway and Perinatal Depression	02/27/2015	OBSERVATIONAL	not-comparable	4,243.75
Swedish Iodine in Pregnancy and Development in Children (SWIDDICH) Study	03/04/2015	INTERVENTIONAL	not-comparable	4,238.75
Longitudinal Study of Intra-Uterine Growth Restriction	03/09/2015	OBSERVATIONAL	not-comparable	4,233.75
Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost	03/10/2015	INTERVENTIONAL	not-comparable	4,232.75
Effects of High Altitude on AMPK Activation	03/18/2015	OBSERVATIONAL	not-comparable	4,224.75
Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)	03/19/2015	INTERVENTIONAL	not-comparable	4,223.75
Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer	03/24/2015	INTERVENTIONAL	not-comparable	4,218.75
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)	03/26/2015	INTERVENTIONAL	not-comparable	4,216.75
Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer	03/27/2015	INTERVENTIONAL	not-comparable	4,215.75
POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer	03/30/2015	INTERVENTIONAL	not-comparable	4,212.75
Positive Airway Pressure, Sleep Apnea, and the Placenta (PAP-SAP)	04/09/2015	INTERVENTIONAL	not-comparable	4,202.75
Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy	04/21/2015	INTERVENTIONAL	not-comparable	4,190.75
Cyrolipolysis vs Cyrolipolysis and Subcision for Cellulite	04/28/2015	INTERVENTIONAL	not-comparable	4,183.75
TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors	04/29/2015	INTERVENTIONAL	not-comparable	4,182.75
TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors	04/29/2015	INTERVENTIONAL	not-comparable	4,182.75
Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer Patients	04/30/2015	OBSERVATIONAL	not-comparable	4,181.75
Safety and Durability of Sirolimus for Treatment of LAM	05/04/2015	OBSERVATIONAL	not-comparable	4,177.75
Vitamin D and Angiogenic Markers in Odense Child Cohort 1	05/06/2015	OBSERVATIONAL	not-comparable	4,175.75
Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab	05/07/2015	INTERVENTIONAL	not-comparable	4,174.75
Placental Passage and Disposition of Drugs: A Physiology-based Approach	05/08/2015	OBSERVATIONAL	not-comparable	4,173.75
The Vitamin D and Fetal Bone Length Study (VITFBL)	05/08/2015	OBSERVATIONAL	not-comparable	4,173.75
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	05/18/2015	INTERVENTIONAL	not-comparable	4,163.75
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer	05/27/2015	INTERVENTIONAL	not-comparable	4,154.75
Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery	05/28/2015	INTERVENTIONAL	not-comparable	4,153.75
Infant Microbiota and Probiotic Intake Study	05/29/2015	INTERVENTIONAL	not-comparable	4,152.75
Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI	06/04/2015	OBSERVATIONAL	not-comparable	4,146.75
Comparison of Axillary Sentinel Lymph Node Biopsy Versus no Axillary Surgery	06/09/2015	INTERVENTIONAL	not-comparable	4,141.75
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers	06/09/2015	INTERVENTIONAL	not-comparable	4,141.75
Ovarian Reserve After Cancer: Longitudinal Effects	06/09/2015	OBSERVATIONAL	not-comparable	4,141.75
Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates	06/15/2015	OBSERVATIONAL	not-comparable	4,135.75
Laparoscopic Surgery for Severe Recto-vaginal Endometriosis	06/15/2015	OBSERVATIONAL	not-comparable	4,135.75
Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer	06/18/2015	INTERVENTIONAL	not-comparable	4,132.75
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score	06/19/2015	INTERVENTIONAL	not-comparable	4,131.75
Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer	06/26/2015	INTERVENTIONAL	not-comparable	4,124.75
The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer	06/30/2015	INTERVENTIONAL	not-comparable	4,120.75
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma	07/01/2015	INTERVENTIONAL	not-comparable	4,119.75
A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer	07/02/2015	INTERVENTIONAL	not-comparable	4,118.75
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer	07/07/2015	INTERVENTIONAL	not-comparable	4,113.75
A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma	07/07/2015	INTERVENTIONAL	not-comparable	4,113.75
Management of Low-risk (Grade I and II) DCIS	07/08/2015	INTERVENTIONAL	not-comparable	4,112.75
Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer	07/10/2015	INTERVENTIONAL	not-comparable	4,110.75
White Adipose Tissue in Pregnancy Study	07/14/2015	OBSERVATIONAL	not-comparable	4,106.75
Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors	07/15/2015	INTERVENTIONAL	not-comparable	4,105.75
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer	07/20/2015	INTERVENTIONAL	not-comparable	4,100.75
Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable Communities	07/31/2015	INTERVENTIONAL	not-comparable	4,089.75
Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer	08/04/2015	INTERVENTIONAL	not-comparable	4,085.75
Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer	08/20/2015	OBSERVATIONAL	not-comparable	4,069.75
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH	08/20/2015	INTERVENTIONAL	not-comparable	4,069.75
Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer	08/20/2015	OBSERVATIONAL	not-comparable	4,069.75
Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer	08/28/2015	INTERVENTIONAL	not-comparable	4,061.75
Preovulatory Uterine Flushing With Saline as a Treatment for Unexplained Infertility	09/03/2015	INTERVENTIONAL	not-comparable	4,055.75
Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer	09/04/2015	OBSERVATIONAL	not-comparable	4,054.75
Biomarker Guided Treatment in Gynaecological Cancer	09/07/2015	INTERVENTIONAL	not-comparable	4,051.75
Treatments for Urogynaecological Problems and Patient Selfreports	09/15/2015	OBSERVATIONAL	not-comparable	4,043.75
Fetoscopic Endoluminal Tracheal Occlusion in Severe Left Congenital Diaphragmatic Hernia	09/15/2015	INTERVENTIONAL	not-comparable	4,043.75
Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer	09/29/2015	INTERVENTIONAL	not-comparable	4,029.75
Effect of Brief-tele Support on Attendance at Physiotherapy Sessions	09/30/2015	INTERVENTIONAL	not-comparable	4,028.75
Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 65	10/01/2015	INTERVENTIONAL	not-comparable	4,027.75
Muscle Loss and Fatigue as a Consequence of Radiotherapy	10/05/2015	OBSERVATIONAL	not-comparable	4,023.75
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer	10/08/2015	INTERVENTIONAL	not-comparable	4,020.75
Uterine Transplantation for the Treatment of Uterine Factor Infertility	10/09/2015	INTERVENTIONAL	not-comparable	4,019.75
Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy	10/12/2015	INTERVENTIONAL	not-comparable	4,016.75
PIERS and BIS, sFIT:PIGF, Adrenomedullin	10/19/2015	OBSERVATIONAL	not-comparable	4,009.75
Toronto Gestational Glucose Tolerance Cohort	10/21/2015	OBSERVATIONAL	not-comparable	4,007.75
Investigating the Impact of Obesity on Pubertal Development in Girls	10/22/2015	OBSERVATIONAL	not-comparable	4,006.75
Beauty from Within Community Screening Project	10/28/2015	OBSERVATIONAL	not-comparable	4,000.75
Anisotropic Textile Braces for Adolescent Idiopathic Scoliosis	10/28/2015	INTERVENTIONAL	not-comparable	4,000.75
Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors	10/30/2015	INTERVENTIONAL	not-comparable	3,998.75
Vasculitis Pregnancy Registry	11/02/2015	OBSERVATIONAL	not-comparable	3,995.75
AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)	11/03/2015	OBSERVATIONAL	not-comparable	3,994.75
Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer	11/04/2015	INTERVENTIONAL	not-comparable	3,993.75
Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	11/04/2015	INTERVENTIONAL	not-comparable	3,993.75
Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Congenital Diaphragm Hernia	11/04/2015	INTERVENTIONAL	not-comparable	3,993.75
Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device	11/09/2015	INTERVENTIONAL	not-comparable	3,988.75
Latent Structure of Multi-level Assessments and Predictors of Outcomes for Women in Recovery	11/10/2015	OBSERVATIONAL	not-comparable	3,987.75
Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)	11/16/2015	INTERVENTIONAL	not-comparable	3,981.75
[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer	11/18/2015	INTERVENTIONAL	not-comparable	3,979.75
Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial	11/20/2015	INTERVENTIONAL	not-comparable	3,977.75
THE INFLUENCE OF COGNITIVE BEHAVIORAL THERAPY IN SEXUAL DYSFUNCTION FEMALE: Randomized Clinical Trial	11/24/2015	INTERVENTIONAL	not-comparable	3,973.75
Tomosynthesis Mammographic Imaging Screening Trial	11/27/2015	INTERVENTIONAL	not-comparable	3,970.75
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)	12/03/2015	INTERVENTIONAL	not-comparable	3,964.75
Adjuvant Trastuzumab, Pertuzumab Plus Docetaxel in the Treatment of Early HER2-positive Breast Cancer	12/09/2015	INTERVENTIONAL	not-comparable	3,958.75
Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	12/11/2015	INTERVENTIONAL	not-comparable	3,956.75
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT	12/22/2015	INTERVENTIONAL	not-comparable	3,945.75
TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature	12/30/2015	INTERVENTIONAL	not-comparable	3,937.75
Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010)	12/30/2015	INTERVENTIONAL	not-comparable	3,937.75
Lateral Episiotomy or Not in Vacuum Assisted Delivery in Non-parous Women	12/30/2015	INTERVENTIONAL	not-comparable	3,937.75